TRCT
FLACU

Tower Research Capital (TRC)’s Frazier Lifesciences Acquisition Corporation Unit FLACU Stock Holding History

Tower Research Capital (TRC)’s Portfolio FLACU Stock Details FLACU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-470
Closed -$5K – 7017
2021
Q4 		$5K Hold
470
– – ﹤0.01% 5254
2021
Q3 		$5K Hold
470
– – ﹤0.01% 4924
2021
Q2 		$5K Hold
470
– – ﹤0.01% 4769
2021
Q1 		$5K Buy
470
+440
+1,467% +$4.69K ﹤0.01% 4727
2020
Q4 		$0 Buy
+30
New +$313 ﹤0.01% 5514

Other funds holding FLACU

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
CIM
Cowen Investment Management New York $12M AUM 1.47% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return

Tower Research Capital (TRC)'s FLACU Position: Q1 2022 in Review

Tower Research Capital (TRC) sold out of Frazier Lifesciences Acquisition Corporation Unit (FLACU) in Q1 2022, closing a stake of 470 shares — an estimated $5K sold.

Tower Research Capital (TRC) first reported a position in FLACU in Q4 2020 and held it in 5 quarters. The position peaked at $5K in Q4 2021. 21 funds tracked by Wall St. Rank hold FLACU as of Q1 2022.

  • Tower Research Capital (TRC) reported no remaining Frazier Lifesciences Acquisition Corporation Unit position as of Q1 2022 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 470 Frazier Lifesciences Acquisition Corporation Unit shares in Q1 2022, an estimated $5K.
  • Tower Research Capital (TRC) first reported a position in Frazier Lifesciences Acquisition Corporation Unit in Q4 2020 and held it in 5 quarters.
  • Tower Research Capital (TRC)'s Frazier Lifesciences Acquisition Corporation Unit position peaked at $5K in Q4 2021.
  • 21 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Unit as of Q1 2022.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2022, filed 12 May 2022.